Banque de Luxembourg Investments (BLI)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$307K Hold
2,531
0.01% 166
2025
Q4
$312K Sell
2,531
-8,000
-76% -$972K 0.01% 169
2025
Q3
$1.19M Sell
10,531
-9,500
-47% -$1.08M 0.03% 161
2025
Q2
$2.22M Sell
20,031
-1,700
-8% -$181K 0.06% 156
2025
Q1
$2.42M Sell
21,731
-3,300
-13% -$341K 0.07% 114
2024
Q4
$2.3M Buy
+25,031
New +$2.25M 0.06% 115

Other funds holding GILD

Banque de Luxembourg Investments (BLI)'s GILD Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,531 shares worth $307K. The position accounts for 0.01% of the portfolio, ranked #166.

Banque de Luxembourg Investments (BLI) first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.42M in Q1 2025. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Banque de Luxembourg Investments (BLI) held 2,531 shares of Gilead Sciences worth $307K as of Q1 2026.
  • Banque de Luxembourg Investments (BLI) left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #166 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Gilead Sciences position peaked at $2.42M in Q1 2025.
  • 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.